Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Idexx Laboratories (IDXX)
NASDAQ:IDXX
Holding IDXX?
Track your performance easily
IDXX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$372.50 - $583.39
Previous Close$511.3
Volume333.84K
Average Volume (3M)499.18K
Market Cap
$42.08B
Enterprise Value$42.73B
Total Cash (Recent Filing)$401.59M
Total Debt (Recent Filing)$1.05B
Price to Earnings (P/E)50.7
Beta1.50
Next Earnings
Oct 29, 2024EPS Estimate
$2.68Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)10.09
Shares Outstanding82,305,898
10 Day Avg. Volume366,518
30 Day Avg. Volume499,179
Standard Deviation0.10
R-Squared0.48
Alpha-0.00300
Financial Highlights & Ratios
Price to Book (P/B)26.63
Price to Sales (P/S)11.14
Price to Cash Flow (P/CF)42.50
P/FCF Ratio49.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue11.29
Enterprise Value/Gross Profit19.51
Enterprise Value/Ebitda45.94
Forecast
1Y Price Target
$553.17Price Target Upside6.98% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
Idexx Laboratories News
Bulls Say, Bears Say
Bulls Say
Innovation And Product LaunchesThe Cancer Dx program will offer affordable oncology testing for common canine cancers, boosting future growth potential.
Market ReadinessIDEXX has begun accepting US pre-orders for the inVue platform, indicating market readiness and interest.
Resilience And GrowthIDEXX reiterated their view that pet healthcare is 'highly resilient', supported by advancing standards of care, pet population expansion, and a strengthening pet-parent bond.
Bears Say
Clinic VisitsConcerns persist about driving a positive inflection in clinic visits, impacting near-term recovery assumptions.
Consumer SpendingConsumers are starting to moderate their vet spending, limiting IDEXX's ability to leverage price increases.
Financial OutlookIDXX is grappling with persistent declines in vet visits, which have driven repeated cuts to IDXX’s FY24 outlook.
---
Ownership Overview
1.57% Insiders
30.83% Mutual Funds
50.98% Other Institutional Investors
16.62% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
IDXX FAQ
What was Idexx Laboratories’s price range in the past 12 months?
Idexx Laboratories lowest stock price was $372.50 and its highest was $583.39 in the past 12 months.
What is Idexx Laboratories’s market cap?
Currently, no data Available
When is Idexx Laboratories’s upcoming earnings report date?
Idexx Laboratories’s upcoming earnings report date is Oct 29, 2024 which is in 39 days.
How were Idexx Laboratories’s earnings last quarter?
Idexx Laboratories released its earnings results on Aug 06, 2024. The company reported $2.44 earnings per share for the quarter, missing the consensus estimate of $2.885 by -$0.445.
Is Idexx Laboratories overvalued?
According to Wall Street analysts Idexx Laboratories’s price is currently Undervalued.
Does Idexx Laboratories pay dividends?
Idexx Laboratories does not currently pay dividends.
What is Idexx Laboratories’s EPS estimate?
Idexx Laboratories’s EPS estimate is $2.68.
How many shares outstanding does Idexx Laboratories have?
Idexx Laboratories has 82,305,900 shares outstanding.
What happened to Idexx Laboratories’s price movement after its last earnings report?
Idexx Laboratories reported an EPS of $2.44 in its last earnings report, missing expectations of $2.885. Following the earnings report the stock price went up 3.14%.
Which hedge fund is a major shareholder of Idexx Laboratories?
Among the largest hedge funds holding Idexx Laboratories’s share is Spence Asset Management. It holds Idexx Laboratories’s shares valued at 24M.
---
Idexx Laboratories Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$553.17 (6.98% Upside)
$553.17 (6.98% Upside)
Blogger Sentiment
Bullish
IDXX Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 45.2K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $234.7K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.2%
Last 30 Days ▲ 1.5%
Last 30 Days ▲ 1.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
13.55%
12-Months-Change
Fundamentals
Return on Equity
63.25%
Trailing 12-Months
Asset Growth
18.95%
Trailing 12-Months
Company Description
Idexx Laboratories
Maine-based IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services for the animal veterinary, livestock and poultry, dairy and water testing markets. It operates through the Companion Animal Group; Water Quality Products; Livestock, Poultry and Dairy; and Other segments.
---
IDXX Company Deck
---
IDXX Earnings Call
Q2 2024
0:00 / 0:00
---
IDXX Revenue Breakdown
34.93% Reference laboratory diagnostic and consulting services
32.46% IDEXX VetLab consumables
9.41% Rapid assay products
7.63% Veterinary software, services and diagnostic imaging systems
15.58% Other
---
IDXX Stock 12 Month Forecast
Average Price Target
$553.17
▲(6.98% Upside)
Technical Analysis
Best Analysts Covering IDXX
1 Year
1 Year Success Rate
13/19 ratings generated profit
1 Year Average Return
+19.70%
reiterated a buy rating last month
Copying Erin Wright's trades and holding each position for 1 Year would result in 68.42% of your transactions generating a profit, with an average return of +19.70% per trade.
---